An innovative device in the management of female urodynamic stress incontinence: a perception survey.


Journal

Minerva ginecologica
ISSN: 1827-1650
Titre abrégé: Minerva Ginecol
Pays: Italy
ID NLM: 0400731

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 2 10 2020
medline: 29 10 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest. A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen The device was effective (60%) independently from severity of Incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. Also compliance with the device was satisfactory (up to 73%). Clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects. Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.

Sections du résumé

BACKGROUND BACKGROUND
Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest.
METHODS METHODS
A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen
RESULTS RESULTS
The device was effective (60%) independently from severity of Incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. Also compliance with the device was satisfactory (up to 73%). Clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects.
CONCLUSIONS CONCLUSIONS
Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.

Identifiants

pubmed: 33000935
pii: S0026-4784.20.04675-4
doi: 10.23736/S0026-4784.20.04675-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-228

Auteurs

Marco Soligo (M)

Unit of Urogynecology, Department of Woman, Mother, and Neonate, Buzzi Children's Hospital, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy - dr@marcosoligo.it.

Marco Torella (M)

Department of Gynecology, Obstetric and Reproductive Science, Second University of Naples, Naples, Italy.

Matteo Balzarro (M)

Department of Urology, University Hospital of Verona, Verona, Italy.

Maria G Matarazzo (MG)

Gynecological Clinic, University Polyclinic of Catania, Catania, Italy.

Andrea Braga (A)

Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Mendrisio, Switzerland.

Maurizio Serati (M)

Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH